Volume 30, Number 1—January 2024
Research
Disease-Associated Streptococcus pneumoniae Genetic Variation
Table 2
Evaluation indicators | 10,713 k-mer predictors |
886 k-mer predictors |
8 k-mer predictors |
|||||
---|---|---|---|---|---|---|---|---|
Resubstitution estimate | 10-fold cross-validation estimate | Resubstitution estimate | 10-fold cross-validation estimate | Resubstitution estimate | 10-fold cross-validation estimate | |||
Accuracy | 98.60 | 93.23 | 96.42 | 90.81 | 90.93 | 90.04 | ||
Balanced accuracy | 98.65 | 93.60 | 96.61 | 91.28 | 91.48 | 90.89 | ||
Sensitivity | 99.13 | 94.48 | 97.91 | 92.87 | 94.27 | 93.72 | ||
Specificity | 98.18 | 92.71 | 95.31 | 89.69 | 88.70 | 88.07 | ||
PPV | 97.71 | 90.27 | 93.98 | 86.27 | 84.81 | 83.65 | ||
NPV | 99.31 | 95.63 | 98.39 | 94.48 | 95.85 | 95.18 | ||
Kappa | 0.97 | 0.86 | 0.93 | 0.81 | 0.81 | 0.80 |
*Values are percentages except for kappa, which is reported as a value ranging from –1 to 1. NPV, negative predictive value; PPV, positive predicitive value.
1These authors contributed equally to this article.
Page created: November 24, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.